Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance
- PMID: 38278160
- DOI: 10.1016/S2214-109X(23)00554-5
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance
Abstract
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions required to mitigate the antimicrobial resistance pandemic are a direct threat to success. We argue that evidence suggests a need to prioritise and support infection prevention interventions (ie, clean water and safe sanitation, increased vaccine coverage, and enhanced infection prevention measures for food production in the Global South contrary to the focus on research and development of new antibiotics in the Global North) and to recalibrate global funding resources to address this need. We call on global leaders to redress the current response, which threatens mitigation of the antimicrobial resistance pandemic.
Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests EC has provided two lectures on antimicrobial stewardship at public engagement events and health-care worker educational events, which were funded by Pfizer, and she has received honoraria for her time and contribution. ACG has received consulting fees from Aché, Eurofarma, Uniã Quimica, and The Wellcome Trust and honoraria from bioMerieux, Eurofarma, MSD, Pfizer, and Sandos. MSD and Pfizer have supported her attendance at meetings or travel, or both. She participates on data safety monitoring boards or advisory boards of Aché, Eurofarma, MSD, Pfizer, Sandoz, United Medical, and Uniāo Quimica. She is a member of the Scientific Advisory Committee for GARDP, a member of the Health 1 Area Coordination Board, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), and is a researcher of the Brazilian National Council for Scientific and Technological Development. All other authors declare no competing interests.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
